China Mengniu Dairy Company Limited - CIADF

CIADF Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
CIADF	-40.8	0	0	0	-12.9	-42.6	-74.9	-63.9	-65.1	92.2
S&P 500	1.0	3.7	2.1	2.3	8.2	25.4	31.0	80.6	196.5	33856.2

Compare CIADF with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	CIADF
name	China Mengniu Dairy Company Limited
price	1.48
changes percentage	-40.8
change	-1.02
day low	1.48
day high	2.5
year high	2.58
year low	1.48
market cap	5796019182
price avg 50	1.48
price avg 200	1.8161
exchange	PNK
volume	5000
avg volume	0
open	2.5
previous close	None
eps	0.15
pe	9.87
earnings announcement	2025-03-24T10:59:00.000+0000
shares outstanding	3916229177
timestamp	2025-01-17 20:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 56.3%

Overall Quarterly Financial Health: 33.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	98624041000	92593322000	6.51
gross profit	36640095000	32689782000	12.08
gross profit ratio	0.37	0.35	5.23
research and development expenses	0	465874941	-100.00
operating expenses	29912236000	26773900000	11.72
interest income	1675555000	1385385000	20.95
interest expense	1569281000	1125263000	39.46
ebitda	11182210000	10505864000	6.44
ebitdaratio	0.11	0.12	-3.92
operating income	6727859000	8048634000	-16.41
operating income ratio	0.07	0.09	-21.52
net income	4809197000	5302972000	-9.31
net income ratio	0.05	0.06	-14.86
eps	1.22	1.52	-19.74

Overall Score of Annual Income Statement

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 98,624 million in 2023 from 92,593 million in 2022 representing a change of 6.51%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 36,640 million in 2023 from 32,690 million in 2022 representing a change of 12.08%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 11,182 million in 2023 from 10,506 million in 2022 representing a change of 6.44%. The increase in EBITDA indicates improved operational efficiency and profitability.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2023 from 466 million in 2022 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 29,912 million in 2023 from 26,774 million in 2022 representing a change of 11.72%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to 6,728 million in 2023 from 8,049 million in 2022 representing a change of -16.41%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 4,809 million in 2023 from 5,303 million in 2022 representing a change of -9.31%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.22 in 2023 from 1.22 in 2022 representing a change of -19.74%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
revenue	22335250000	22335250000	0.0
gross profit	8819266500	8819266500	0.0
gross profit ratio	0.39	0.39	0.0
research and development expenses	0	0	NaN
operating expenses	7355042000	7355042000	0.0
interest income	0	0	NaN
interest expense	0	0	NaN
ebitda	2050925499	2050925499	0.0
ebitdaratio	0.09	0.09	0.0
operating income	1464224500	1464224500	0.0
operating income ratio	0.07	0.07	0.0
net income	1222905000	1222905000	0.0
net income ratio	0.05	0.05	0.0
eps	0.31	0.31	0.0

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	115219951000	117813205000	-2.20
total liabilities	64568240000	67761407000	-4.71
total equity	50651711000	50051798000	1.20
cash and cash equivalents	12443800000	12765829000	-2.52
short term investments	8531769000	6827398000	24.96
long term investments	30519892000	33360026098	-8.51
total current assets	34128262000	36777074000	-7.20
total non current assets	81091689000	81036131000	0.07
total current liabilities	32594058000	33153252000	-1.69
total non current liabilities	31974182000	34608155000	-7.61
common stock	358143000	359948000	-0.50
retained earnings	39027337000	29447875000	32.53
total debt	37410755000	39108605000	-4.34

Overall Score of Annual Balance Sheet

0.6 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 115,220 million in 2023 from 117,813 million in 2022 representing a change of -2.2%. Suggesting a decrease in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 12,444 million in 2023 from 12,766 million in 2022 representing a change of -2.52%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 34,128 million in 2023 from 36,777 million in 2022 representing a change of -7.2%. This indicates a worsen liquidity position.

  Common Stock: Common Stock decreased to 358 in 2023 from 360 in 2022 representing a change of -0.5%. This indicates a decrease in ownership interest.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 64,568 million in 2023 from 67,761 million in 2022 representing a change of -4.71%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 50,652 million in 2023 from 50,052 million in 2022 representing a change of 1.2%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 8,532 million in 2023 from 6,827 million in 2022 representing a change of 24.96%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 32,594 million in 2023 from 33,153 million in 2022 representing a change of -1.69%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 39,027 million in 2023 from 29,448 million in 2022 representing a change of 32.53%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 37,411 million in 2023 from 39,109 million in 2022 representing a change of -4.34%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	116723294000	116723294000	0.00
total liabilities	65604691000	65604691000	0.00
total equity	51118603000	51118603000	0.00
cash and cash equivalents	18436774000	18436774000	0.00
short term investments	6445757000	6445757000	0.00
long term investments	27186715000	27186715000	0.00
total current assets	37153728000	37153728000	0.00
total non current assets	79569566000	79569566000	0.00
total current liabilities	37666599000	37666599000	0.00
total non current liabilities	27938092000	27938092000	0.00
common stock	358143000	358143000	0.00
retained earnings	39548789000	39548789000	0.00
total debt	41562293000	40386114000	2.91

Overall Score of Quarterly Balance Sheet

0.0 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Debt: Total Debt increased to 41,562 million in 2024Q2 from 40,386 million in 2024Q1 representing a change of 2.91%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	1508447000	-2398312000	162.90
operating cash flow	8349338000	8333051000	0.20
free cash flow	4214627000	3268615000	28.94
capital expenditure	-4134711000	-5064436000	18.36
depreciation and amortization	3300742000	2878248000	14.68
deferred income tax	0	0	NaN
stock based compensation	132268000	698087000	-81.05
accounts payables	0	0	NaN
inventory	1669051000	-1157830000	244.15
acquisitions net	641640000	215415000	197.86
investments in property plant and equipment	-3862573000	-5064436000	23.73
net cash used for investing activites	-285826000	-14862347000	98.08
debt repayment	-1770699000	7724438000	-122.92
common stock issued	155637000	27034000	475.71
common stock repurchased	-817991000	-253946000	-222.11
dividends paid	-1588015000	-1506669000	-5.40
net cash used provided by financing activities	-6802385000	4147103000	-264.03
cash at end of period	7201880000	5693433000	26.49
accounts receivables	-130341000	272965207	-147.75
cash at beginning of period	5693433000	8091745000	-29.64

Overall Score of Annual Cashflow Statement

0.71 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 1,508 million in 2023 from -2,398 million in 2022 representing a change of 162.9%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 8,349 million in 2023 from 8,333 million in 2022 representing a change of 0.2%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 4,215 million in 2023 from 3,269 million in 2022 representing a change of 28.94%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to 132 million in 2023 from 698 million in 2022 representing a change of -81.05%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Receivables: Accounts Receivables decreased to -130 million in 2023 from 273 million in 2022 representing a change of -147.75%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -4,135 million in 2023 from -5,064 million in 2022 representing a change of 18.36%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Dividends Paid: Dividends Paid decreased to -1,588 million in 2023 from -1,507 million in 2022 representing a change of -5.4%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
operating cash flow	959946500	959946500	0.0
free cash flow	168217500	168217500	0.0
capital expenditure	-791729000	-791729000	0.0
depreciation and amortization	859194000	859194000	0.0
deferred income tax	0	0	NaN
stock based compensation	28727500	28727500	0.0
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	-791729000	-791729000	0.0
net cash used for investing activites	368844000	368844000	0.0
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-25427500	-25427500	0.0
dividends paid	-962179000	-962179000	0.0
net cash used provided by financing activities	741146000	741146000	0.0
net change in cash	2075478500	2075478500	0.0
cash at end of period	2075478500	2075478500	0.0
cash at beginning of period	0	0	NaN

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q4 2023 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	24.94	23.43	6.41
net income per share	1.22	1.34	-9.40
operating cash flow per share	2.11	2.11	0.10
free cash flow per share	1.07	0.83	28.82
cash per share	5.3	4.96	6.96
book value per share	12.81	12.67	1.10
tangible book value per share	7.35	6.91	6.36
shareholders equity per share	11.21	10.15	10.43
interest debt per share	9.86	10.18	-3.21
market cap	71169574135.32	123509369106.6	-42.38
enterprise value	96136529135.32	149852145106.6	-35.85
pe ratio	14.8	23.29	-36.46
price to sales ratio	0.72	1.33	-45.90
pocfratio	8.52	14.82	-42.49
pfcf ratio	16.89	37.79	-55.31
pb ratio	1.61	3.08	-47.87
ptb ratio	1.61	3.08	-47.87
ev to sales	0.97	1.62	-39.77
enterprise value over ebitda	8.6	14.26	-39.73
ev to operating cash flow	11.51	17.98	-35.97
ev to free cash flow	22.81	45.85	-50.25
earnings yield	0.07	0.04	57.38
free cash flow yield	0.06	0.03	123.77
debt to equity	0.84	0.98	-13.45
debt to assets	0.32	0.33	-2.19
net debt to ebitda	2.23	2.51	-10.96
current ratio	1.05	1.11	-5.61
interest coverage	4.29	7.15	-40.06
income quality	1.74	1.28	35.47
dividend yield	0.02	0.01	82.91
payout ratio	0.33	0.28	16.22
sales general and administrative to revenue	0.05	0.05	0.24
research and ddevelopement to revenue	0	0.01	-100.00
intangibles to total assets	0.19	0.19	-2.99
capex to operating cash flow	0.5	0.61	-18.52
capex to revenue	0.04	0.05	-23.35
capex to depreciation	1.25	1.76	-28.81
stock based compensation to revenue	0.0	0.01	-82.21
graham number	17.51	17.51	0.03
roic	0.06	0.07	-17.68
return on tangible assets	0.05	0.06	-7.93
graham net net	-9.56	-10.47	8.76
working capital	1534204000	3623822000	-57.66
tangible asset value	29081430000	27316868000	6.46
net current asset value	-30439978000	-30984333000	1.76
invested capital	48385581000	51432971000	-5.92
average receivables	3664423000	3909965000	-6.28
average payables	9850038000	9502268500	3.66
average inventory	7080913500	7279431000	-2.73
days sales outstanding	13.58	14.43	-5.90
days payables outstanding	55.94	62.15	-10.00
days of inventory on hand	35.85	49.19	-27.12
receivables turnover	26.88	25.3	6.27
payables turnover	6.53	5.87	11.11
inventory turnover	10.18	7.42	37.21
roe	0.11	0.13	-17.95
capex per share	1.05	1.28	-18.43

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 14.80 on 2023-12-31 from 23.29 on 2022-12-31, representing a change of -36.46%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.05 on 2023-12-31 from 1.11 on 2022-12-31, representing a change of -5.61%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.84 on 2023-12-31 from 0.98 on 2022-12-31, representing a change of -13.45%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q2	2023-12-31 Q4	Q/Q change %
CIADF
calendar year	2024	2023	NaN
revenue per share	11.36	12.04	-5.67
net income per share	0.62	0.45	37.17
operating cash flow per share	0.49	1.24	-60.68
free cash flow per share	0.09	0.73	-88.31
cash per share	6.33	5.32	19.01
book value per share	13.0	12.84	1.25
tangible book value per share	7.56	6.99	8.21
shareholders equity per share	11.37	11.23	1.25
interest debt per share	10.57	9.48	11.45
market cap	51207868919.53	70987516523.43	-27.86
enterprise value	74333387919.53	95954471523.43	-22.53
pe ratio	5.23	9.92	-47.24
price to sales ratio	1.15	1.49	-23.29
pocfratio	26.67	14.49	84.06
pfcf ratio	152.21	24.59	519.10
pb ratio	1.14	1.6	-28.52
ptb ratio	1.14	1.6	-28.52
ev to sales	1.66	2.02	-17.62
enterprise value over ebitda	18.12	24.78	-26.86
ev to operating cash flow	38.72	19.59	97.66
ev to free cash flow	220.94	33.23	564.85
earnings yield	0.05	0.03	89.55
free cash flow yield	0.01	0.04	-83.85
debt to equity	0.93	0.84	10.08
debt to assets	0.36	0.32	9.67
net debt to ebitda	5.64	6.45	-12.55
current ratio	0.99	1.05	-5.80
interest coverage	0	0	NaN
income quality	0.78	2.74	-71.34
dividend yield	0.04	0	NaN
payout ratio	0.79	0	NaN
sales general and administrative to revenue	0.04	0.05	-19.31
research and ddevelopement to revenue	0	0.01	-100.00
intangibles to total assets	0.18	0.2	-8.56
capex to operating cash flow	0.82	0.41	100.88
capex to revenue	0.04	0.04	-16.28
capex to depreciation	0.92	1.18	-21.58
stock based compensation to revenue	0.0	-0.0	717.75
graham number	12.62	10.71	17.85
roic	0.02	0.02	39.23
return on tangible assets	0.03	0.02	32.14
graham net net	-8.97	-9.58	6.34
working capital	-512871000	1534204000	-133.43
tangible asset value	29733195000	27564871000	7.87
net current asset value	-28450963000	-30439978000	6.53
invested capital	46899960000	49902140000	-6.02
average receivables	None	None	NaN
average payables	None	None	NaN
average inventory	None	None	NaN
days sales outstanding	6.93	6.95	-0.34
days payables outstanding	30.52	27.76	9.93
days of inventory on hand	19.03	17.79	6.96
receivables turnover	12.99	12.95	0.34
payables turnover	2.95	3.24	-9.03
inventory turnover	4.73	5.06	-6.51
roe	0.05	0.04	35.49
capex per share	0.4	0.51	-21.02

• Negative

  ROE: Return on Equity (ROE) increased to 0.05 on 2024-06-30 Q2 from 0.04 on 2023-12-31 Q4, representing a change of 35.49%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 5.23 on 2024-06-30 Q2 from 9.92 on 2023-12-31 Q4, representing a change of -47.24%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio decreased to 0.99 on 2024-06-30 Q2 from 1.05 on 2023-12-31 Q4, representing a change of -5.80%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.93 on 2024-06-30 Q2 from 0.84 on 2023-12-31 Q4, representing a change of 10.08%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 2.11 which is higher than current price 1.48, indicates the company may be undervalued.